Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas R Latimer

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Pharmacoeconomics|August 29, 2024
MPES-R: Multi-Parameter Evidence Synthesis in R for Survival Extrapolation-A TutorialAsh Bullement, Mark Edmondson-Jones, Patricia Guyot, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 22, 2020
Extrapolation of Survival Curves Using Standard Parametric Models and Flexible Parametric Spline Models: Comparisons in Large Registry Cohorts with Advanced CancerJodi Gray, Thomas Sullivan, Nicholas R Latimer, et al.
BMC Health Services Research|May 4, 2021
Challenges in valuing and paying for combination regimens in oncology: reporting the perspectives of a multi-stakeholder, international workshopNicholas R Latimer, Daniel Pollard, Adrian Towse, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 14, 2023
Survival Extrapolation Incorporating General Population Mortality Using Excess Hazard and Cure Models: A TutorialMichael J Sweeting, Mark J Rutherford, Dan Jackson, et al.
Pharmacoeconomics - Open|May 27, 2018
Developing Accessible, Pictorial Versions of Health-Related Quality-of-Life Instruments Suitable for Economic Evaluation: A Report of Preliminary Studies Conducted in Canada and the United KingdomDavid G T Whitehurst, Nicholas R Latimer, Aura Kagan, et al.
Pharmacoeconomics|September 20, 2024
An Evaluation of an Algorithm for the Selection of Flexible Survival Models for Cancer Immunotherapies: Pass or Fail?Nicholas R Latimer, Kurt Taylor, Anthony J Hatswell, et al.
Statistical Methods in Medical Research|October 31, 2025
Using inverse probability of censoring weighting to estimate hypothetical estimands in clinical trials: Should we implement stabilisation, and if so how?Jingyi Xuan, Shahrul Mt-Isa, Nicholas R Latimer, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|September 28, 2012
Modelling the cost-effectiveness of alcohol screening and brief interventions in primary care in EnglandRobin C Purshouse, Alan Brennan, Rachid Rafia, et al.
Pharmacoeconomics|August 23, 2024
Treatment Effect Waning in Immuno-oncology Health Technology Assessments: A Review of Assumptions and Supporting Evidence with Proposals to Guide ModellingKurt Taylor, Nicholas R Latimer, Thomas Douglas, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 23, 2014
Adjusting survival time estimates to account for treatment switching in randomized controlled trials--an economic evaluation context: methods, limitations, and recommendationsNicholas R Latimer, Keith R Abrams, Paul C Lambert, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Pharmacoeconomics|August 29, 2024
MPES-R: Multi-Parameter Evidence Synthesis in R for Survival Extrapolation-A TutorialAsh Bullement, Mark Edmondson-Jones, Patricia Guyot, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 22, 2020
Extrapolation of Survival Curves Using Standard Parametric Models and Flexible Parametric Spline Models: Comparisons in Large Registry Cohorts with Advanced CancerJodi Gray, Thomas Sullivan, Nicholas R Latimer, et al.
BMC Health Services Research|May 4, 2021
Challenges in valuing and paying for combination regimens in oncology: reporting the perspectives of a multi-stakeholder, international workshopNicholas R Latimer, Daniel Pollard, Adrian Towse, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 14, 2023
Survival Extrapolation Incorporating General Population Mortality Using Excess Hazard and Cure Models: A TutorialMichael J Sweeting, Mark J Rutherford, Dan Jackson, et al.
Pharmacoeconomics - Open|May 27, 2018
Developing Accessible, Pictorial Versions of Health-Related Quality-of-Life Instruments Suitable for Economic Evaluation: A Report of Preliminary Studies Conducted in Canada and the United KingdomDavid G T Whitehurst, Nicholas R Latimer, Aura Kagan, et al.
Pharmacoeconomics|September 20, 2024
An Evaluation of an Algorithm for the Selection of Flexible Survival Models for Cancer Immunotherapies: Pass or Fail?Nicholas R Latimer, Kurt Taylor, Anthony J Hatswell, et al.
Statistical Methods in Medical Research|October 31, 2025
Using inverse probability of censoring weighting to estimate hypothetical estimands in clinical trials: Should we implement stabilisation, and if so how?Jingyi Xuan, Shahrul Mt-Isa, Nicholas R Latimer, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|September 28, 2012
Modelling the cost-effectiveness of alcohol screening and brief interventions in primary care in EnglandRobin C Purshouse, Alan Brennan, Rachid Rafia, et al.
Pharmacoeconomics|August 23, 2024
Treatment Effect Waning in Immuno-oncology Health Technology Assessments: A Review of Assumptions and Supporting Evidence with Proposals to Guide ModellingKurt Taylor, Nicholas R Latimer, Thomas Douglas, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 23, 2014
Adjusting survival time estimates to account for treatment switching in randomized controlled trials--an economic evaluation context: methods, limitations, and recommendationsNicholas R Latimer, Keith R Abrams, Paul C Lambert, et al.
Pageof 5